Nationwide Children’s gene therapy spinout raises $2.5M to test muscular dystrophy treatment

Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.

A gene therapy startup that spun out of Nationwide Children’s Hospital six months ago has raised $2.5 million toward testing a treatment for a form of muscular dystrophy in patients.

Myonexus Therapeutics Inc. is the fourth company to come out of gene therapy research at the Columbus hospital and the only one located in Central Ohio.

Click here to read the complete article, and see related press release.
Originally published December 13, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: